|
1
|
Rini BI, Campbell SC and Escudier B: Renal
cell carcinoma. Lancet. 373:1119–1132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yagoda A, Abi-Rached B and Petrylak D:
Chemotherapy for advanced renal-cell carcinoma: 1983–1993. Semin
Oncol. 22:42–60. 1995.PubMed/NCBI
|
|
3
|
Chang HY and Yang X: Proteases for cell
suicide: Functions and regulation of caspases. Microbiol Mol Biol
Rev. 64:821–846. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Burz C, Berindan-Neagoe I, Balacescu O and
Irimie A: Apoptosis in cancer: Key molecular signaling pathways and
therapy targets. Acta Oncol. 48:811–821. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Holcik M, Lefebvre C, Yeh C, Chow T and
Korneluk RG: A new internal-ribosome-entry-site motif potentiates
XIAP-mediated cytoprotection. Nat Cell Biol. 1:190–192. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Holcik M and Korneluk RG: XIAP, the
guardian angel. Nat Rev Mol Cell Biol. 2:550–556. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Devi GR: XIAP as target for therapeutic
apoptosis in prostate cancer. Drug News Perspect. 17:127–134. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mizutani Y, Nakanishi H, Li YN, Matsubara
H, Yamamoto K, Sato N, Shiraishi T, Nakamura T, Mikami K, Okihara
K, et al: Overexpression of XIAP expression in renal cell carcinoma
predicts a worse prognosis. Int J Oncol. 30:919–925.
2007.PubMed/NCBI
|
|
9
|
Yan Y, Mahotka C, Heikaus S, Shibata T,
Wethkamp N, Liebmann J, Suschek CV, Guo Y, Gabbert HE, Gerharz CD
and Ramp U: Disturbed balance of expression between XIAP and
Smac/DIABLO during tumour progression in renal cell carcinomas. Br
J Cancer. 91:1349–1357. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang C, Yi XP, Shen H and Li YX:
Targeting X-linked inhibitor of apoptosis protein inhibits
pancreatic cancer cell growth through p-Akt depletion. World J
Gastroenterol. 18:2956–2965. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kwatra SG: Targeting x-linked inhibitor of
apoptosis protein for melanoma therapy: The need for more
homogeneous samples and the importance of cell lines. J Invest
Dermatol. 131:7972011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schimmer AD, Dalili S, Batey RA and Riedl
SJ: Targeting XIAP for the treatment of malignancy. Cell Death
Differ. 13:179–188. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun H, Nikolovska-Coleska Z, Lu J, Meagher
JL, Yang CY, Qiu S, Tomita Y, Ueda Y, Jiang S, Krajewski K, et al:
Design, synthesis, and characterization of a potent, nonpeptide,
cell-permeable, bivalent Smac mimetic that concurrently targets
both the BIR2 and BIR3 domains in XIAP. J Am Chem Soc.
129:15279–15294. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu J, Zhang D, Luo W, Yu J, Li J, Yu Y,
Zhang X, Chen J, Wu XR and Huang C: E3 ligase activity of XIAP RING
domain is required for XIAP-mediated cancer cell migration, but not
for its RhoGDI binding activity. PLoS One. 7:e356822012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang X, Wu Z, Mei Y and Wu M: XIAP
inhibits autophagy via XIAP-Mdm2-p53 signalling. EMBO J.
32:2204–2216. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suzuki Y, Nakabayashi Y and Takahashi R:
Ubiquitin-protein ligase activity of X-linked inhibitor of
apoptosis protein promotes proteasomal degradation of caspase-3 and
enhances its anti-apoptotic effect in Fas-induced cell death. Proc
Natl Acad Sci USA. 98:pp. 8662–8667. 2001; View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gyrd-Hansen M and Meier P: IAPs: From
caspase inhibitors to modulators of NF-kappaB, inflammation and
cancer. Nat Rev Cancer. 10:561–574. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bilim V, Yuuki K, Itoi T, Muto A, Kato T,
Nagaoka A, Motoyama T and Tomita Y: Double inhibition of XIAP and
Bcl-2 axis is beneficial for retrieving sensitivity of renal cell
cancer to apoptosis. Br J Cancer. 98:941–949. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tong W, Harris S, Cao X, Fang H, Shi L,
Sun H, Fuscoe J, Harris A, Hong H, Xie Q, et al: Development of
public toxicogenomics software for microarray data management and
analysis. Mutat Res. 549:241–253. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li CL, Chang L, Guo L, Zhao D, Liu HB,
Wang QS, Zhang P, Du WZ, Liu X, Zhang HT, et al: β-elemene induces
caspase-dependent apoptosis in human glioma cells in vitro through
the upregulation of Bax and Fas/FasL and downregulation of Bcl-2.
Asian Pac J Cancer Prev. 15:10407–10412. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kriajevska M, Fischer-Larsen M, Moertz E,
Vorm O, Tulchinsky E, Grigorian M, Ambartsumian N and Lukanidin E:
Liprin beta 1, a member of the family of LAR transmembrane tyrosine
phosphatase-interacting proteins, is a new target for the
metastasis-associated protein S100A4 (Mts1). J Biol Chem.
277:5229–5235. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Simpson PT, Shoker BS, Barraclough R,
Halliwell N, Rudland PS, Sibson DR and Davies MP: Examination of
tumour histopathology and gene expression in a neu/S100A4
transgenic model of metastatic breast cancer. Int J Exp Pathol.
84:173–184. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Knudsen KA, Soler AP, Johnson KR and
Wheelock MJ: Interaction of alpha-actinin with the cadherin/catenin
cell-cell adhesion complex via alpha-catenin. J Cell Biol.
130:67–77. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Prockop DJ and Kivirikko KI: Collagens:
Molecular biology, diseases, and potentials for therapy. Annu Rev
Biochem. 64:403–434. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Misri S, Pandita S, Kumar R and Pandita
TK: Telomeres, histone code, and DNA damage response. Cytogenet
Genome Res. 122:297–307. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xie A, Odate S, Chandramouly G and Scully
R: H2AX post-translational modifications in the ionizing radiation
response and homologous recombination. Cell Cycle. 9:3602–3610.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Campbell RE, Sala RF, van de Rijn I and
Tanner ME: Properties and kinetic analysis of UDP-glucose
dehydrogenase from group A streptococci. Irreversible inhibition by
UDP-chloroacetol. J Biol Chem. 272:3416–3422. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
García-García MJ and Anderson KV:
Essential role of glycosaminoglycans in Fgf signaling during mouse
gastrulation. Cell. 114:727–737. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schenk G, Duggleby RG and Nixon PF:
Properties and functions of the thiamin diphosphate dependent
enzyme transketolase. Int J Biochem Cell Biol. 30:1297–1318. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ozawa M and Muramatsu T: Reticulocalbin, a
novel endoplasmic reticulum resident Ca(2+)-binding protein with
multiple EF-hand motifs and a carboxyl-terminal HDEL sequence. J
Biol Chem. 268:699–705. 1993.PubMed/NCBI
|
|
32
|
Wang R, Li B, Wang X, Lin F, Gao P, Cheng
SY and Zhang HZ: Inhibiting XIAP expression by RNAi to inhibit
proliferation and enhance radiosensitivity in laryngeal cancer cell
line. Auris Nasus Larynx. 36:332–339. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang S, Li SS, Yang XM, Yin DH and Wang L:
Embelin prevents LMP1-induced TRAIL resistance via inhibition of
XIAP in nasopharyngeal carcinoma cells. Oncol Lett. 11:4167–4176.
2016.PubMed/NCBI
|
|
34
|
Cao Z, Zhang R, Li J, Huang H, Zhang D,
Zhang J, Gao J, Chen J and Huang C: X-linked inhibitor of apoptosis
protein (XIAP) regulation of cyclin D1 protein expression and
cancer cell anchorage-independent growth via its E3 ligase-mediated
protein phosphatase 2A/c-Jun axis. J Biol Chem. 288:20238–20247.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Horn HF and Vousden KH: Coping with
stress: Multiple ways to activate p53. Oncogene. 26:1306–1316.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gaston-Massuet C, Andoniadou CL, Signore
M, Jayakody SA, Charolidi N, Kyeyune R, Vernay B, Jacques TS,
Taketo MM, Le Tissier P, et al: Increased Wingless (Wnt) signaling
in pituitary progenitor/stem cells gives rise to pituitary tumors
in mice and humans. Proc Natl Acad Sci USA. 108:pp. 11482–11487.
2011; View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Papakonstanti EA and Stournaras C: Actin
cytoskeleton architecture and signaling in osmosensing. Methods
Enzymol. 428:227–240. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li A, Zhou T, Guo L and Si J: Collagen
type I regulates beta-catenin tyrosine phosphorylation and nuclear
translocation to promote migration and proliferation of gastric
carcinoma cells. Oncol Rep. 23:1247–1255. 2010.PubMed/NCBI
|
|
39
|
Garrett SC, Varney KM, Weber DJ and
Bresnick AR: S100A4, a mediator of metastasis. J Biol Chem.
281:677–680. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Turner BM: Cellular memory and the histone
code. Cell. 111:285–291. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wen KX, Miliç J, El-Khodor B, Dhana K,
Nano J, Pulido T, Kraja B, Zaciragic A, Bramer WM, Troup J, et al:
The role of DNA methylation and histone modifications in
neurodegenerative diseases: A systematic review. PLoS One.
11:e01672012016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hsu PP and Sabatini DM: Cancer cell
metabolism: Warburg and beyond. Cell. 134:703–707. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fels DR and Koumenis C: The
PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and
tumor growth. Cancer Biol Ther. 5:723–728. 2006. View Article : Google Scholar : PubMed/NCBI
|
